CCM
ARKG icon

Cinctive Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cinctive Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,000
Closed -$1.84M – 509
2022
Q1 		$1.84M Buy
+40,000
New +$1.91M 0.07% 336

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MM
Main Management San Francisco, California $1.37B AUM 19.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Cinctive Capital Management's ARKG Position: Q4 2023 in Review

Cinctive Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2023, closing a stake of 200,005 shares — an estimated $5.57M sold.

Cinctive Capital Management first reported a position in ARKG in Q3 2023 and held it in 1 quarter. The position peaked at $5.57M in Q3 2023. 298 funds tracked by Wall St. Rank hold ARKG as of Q4 2023.

  • Cinctive Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q4 2023 after selling out during the quarter.
  • Cinctive Capital Management sold 200,005 ARK Genomic Revolution ETF shares in Q4 2023, an estimated $5.57M.
  • Cinctive Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2023 and held it in 1 quarter.
  • Cinctive Capital Management's ARK Genomic Revolution ETF position peaked at $5.57M in Q3 2023.
  • 298 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2023.

Based on Cinctive Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.